GleamWall
中文EN

ISRG INTUITIVE SURGICAL INC

Orthopedic, Prosthetic & Surgical Appliances & Supplies · Nasdaq · SEC CIK 1035267 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY20.5%
TTM net income YoY7.7%
TTM EPS YoY9.4%
Revenue 3-yr CAGR19.1%
Net income 3-yr CAGR24.9%

Margins

Gross margin67.2%
Operating margin28.4%
Net margin25.5%
FCF margin31.1%
EBITDA margin—

Returns

ROE18.0%
ROA15.3%
ROIC (approx.)19.9%
Asset turnover0.60x

Leverage & solvency

Liabilities / assets16.7%
Debt / equity0.00x
Current ratio3.33x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.38x
Accruals ratio-5.9%
Payout ratio—
Capex / revenue4.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$3.05B$2.89B$2.77B$2.87B$2.51B$2.44B$2.25B$2.41B
Cost of revenue$964.40M$931.90M$940.30M$961.90M$842.70M$822.10M$795.70M$771.30M
Gross profit$2.08B$1.96B$1.83B$1.90B$1.66B$1.62B$1.46B$1.64B
R&D expense$408.30M$370.60M$361.90M$352.90M$329.40M$313.30M$316.20M$294.70M
SG&A expense$633.40M$617.90M$613.30M$687.10M$573.30M$561.20M$563.40M$612.60M
Operating income$592.60M$971.90M$855.30M$864.30M$759.70M$743.40M$578.10M$734.90M
Pretax income$668.40M$1.05B$940.40M$955.60M$855.20M$832.10M$668.50M$809.80M
Income tax$144.00M$231.40M$114.40M$156.10M$146.00M$167.90M-$35.20M$121.80M
Net income$522.80M$818.10M$821.50M$794.80M$704.40M$658.40M$698.40M$685.70M
EPS (basic)1.502.312.31—1.981.841.95—
EPS (diluted)1.492.292.28—1.951.811.92—
Weighted avg. shares (diluted)351.60M357.30M359.80M—361.80M364.10M364.60M—
Balance sheet
Cash & equivalents$2.98B$2.76B$2.01B$3.37B$2.85B$3.45B$2.62B$2.06B
Short-term investments$1.06B$2.46B$2.51B$2.57B$2.10B$1.92B$1.94B$1.99B
Receivables$1.72B$1.67B$1.60B$1.53B$1.26B$1.27B$1.22B$1.23B
Inventory$2.13B$2.03B$1.95B$1.84B$1.78B$1.67B$1.55B$1.49B
Current assets$8.43B$9.54B$8.81B$9.78B$8.53B$8.75B$7.66B$7.11B
PP&E, net$5.68B$5.55B$5.45B$5.34B$5.15B$4.99B$4.80B$4.65B
Goodwill$557.80M$580.60M$613.20M$370.30M$348.10M$348.70M$347.50M$347.50M
Intangibles$196.70M$198.00M$173.50M$17.10M$14.50M$17.90M$19.60M$23.00M
Total assets$19.35B$20.88B$20.11B$20.46B$19.35B$20.16B$19.22B$18.74B
Current liabilities$2.53B$1.92B$1.91B$2.01B$1.80B$1.69B$1.54B$1.75B
Total liabilities$3.23B$2.58B$2.51B$2.52B$2.31B$2.21B$2.01B$2.21B
Shareholders' equity$15.99B$18.17B$17.47B$17.82B$16.93B$17.85B$17.11B$16.43B
Shares outstanding346.60M353.90M354.40M355.10M354.90M358.40M358.40M356.60M
Cash flow statement
Operating cash flow$1.22B$1.06B$911.90M$892.50M$841.00M$715.40M$581.60M$822.60M
Capital expenditure$113.10M$112.60M$103.30M$162.50M$105.40M$155.30M$116.60M$312.00M
Free cash flow$1.11B$948.40M$808.60M$730.00M$735.60M$560.10M$465.00M$510.60M
Investing cash flow$1.90B-$26.60M-$914.50M-$209.40M$401.00M$260.70M$213.50M-$1.26B
Financing cash flow-$2.89B-$287.90M-$1.35B-$137.50M-$1.84B-$147.80M-$235.80M$49.40M
Stock-based compensation$215.70M$212.80M$209.50M$203.30M$206.00M$199.90M$185.20M$177.00M
Dividends paid————$0———
Share buybacks$2.98B$320.30M$1.12B$201.00M$1.91B$181.00M$0$0

Free plan shows the latest 8 periods; Pro shows all 74 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.